TrialThe oncologist2019

Regorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial.

Rachel P Riechelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.